Regulation And Legal
GlaxoSmithKline Receives ₹52 Crore Tax Refund
GlaxoSmithKline Pharmaceuticals discloses receipt of ₹52 crore tax refund for assessment year 1984-85.
The refund, received on 6th August 2026, follows an order from the CIT-Appeal dated 27th January
